102940 — Kolon Life Science Income Statement
0.000.00%
Last trade - 00:00- KR₩254bn
- KR₩355bn
- KR₩125bn
Annual income statement for Kolon Life Science, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 148,541 | 129,413 | 165,485 | 161,584 | 124,639 |
| Cost of Revenue | |||||
| Gross Profit | 25,559 | 18,896 | 37,202 | 37,139 | 12,411 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 177,296 | 156,440 | 165,939 | 161,823 | 151,867 |
| Operating Profit | -28,754 | -27,027 | -454 | -239 | -27,228 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -80,197 | -43,195 | -4,011 | 4,124 | -33,598 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -92,323 | -43,195 | -1,375 | 4,016 | -33,599 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -92,323 | -43,195 | -1,375 | 2,133 | -30,726 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -92,323 | -43,195 | -1,375 | 2,133 | -30,726 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -7,984 | -3,998 | 122 | 491 | -2,765 |
| Dividends per Share |